ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cell

• Publication date

  1998-03-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-8674(00)81401-4PMID 9529249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Repression of p53-mediated transcription by MDM2: a dual mechanism.

  1997cited by this paper
• Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele.

  1996cited by this paper
• mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

  1996cited by this paper
• In vivo ubiquitination and proteasome-mediated degradation of p53(1).

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Immunoprecipitation and Immunoblotting in Cell Cycle Studies

  1996cited by this paper
• Role of the INK4a locus in tumor suppression and cell mortality.

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• p53 in growth control and neoplasia.

  1996cited by this paper
• Complex structure and regulation of the P16 (MTS1) locus.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

  1995cited by this paper
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

  1995cited by this paper
• A novel p16INK4A transcript.

  1995cited by this paper
• A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.

  1995cited by this paper
• Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

  1995cited by this paper
• Functional p53 protein in human papillomavirus-positive cancer cells.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.

  1994cited by this paper
• Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.

  1994cited by this paper
• Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• p53 Mutation and MDM2 amplification in human soft tissue sarcomas.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

  1993cited by this paper
• Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

  1993cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• Mapping of the p53 and mdm-2 interaction domains.

  1993cited by this paper
• mdm2 expression is induced by wild type p53 activity.

  1993cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• Chromosome 11q13 abnormalities in human cancer.

  1991cited by this paper
• A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

  1991cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• A novel genetic system to detect protein–protein interactions

  1989cited by this paper

• Cellular Senescence Triggered by Food and Environmental Genotoxins

  2026cites this paper
• Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

  2026cites this paper
• miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma.

  2026cites this paper
• Targeting cell cycle checkpoints for glioma therapy.

  2025cites this paper
• Restoration of angiogenic capacity in senescent endothelial cells by a pharmacological reprogramming approach

  2025cites this paper
• Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant

  2025cites this paper
• Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

  2025cites this paper
• Abnormal nuclear and nucleolar immunoreactivity of p16INK4a represents a frameshift alteration in CDKN2A: the E6H4 clone recognizes the "p14ARF::p16INK4a" chimeric protein.

  2025cites this paper
• Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath Tumors

  2025cites this paper
• p14ARF interacts with γ-H2AX and is involved in the DNA damage response.

  2025cites this paper
• Structural dynamics of the wild-type p53 DNA-binding domain and hotspot mutants reveal oncogenic conformational shifts.

  2025cites this paper
• Targeted Inhibition of Colorectal Carcinoma Using a Designed CEA-Binding Protein to Deliver p53 Protein and TCF/LEF Transcription Factor Decoy DNA

  2025cites this paper
• Tumor microenvironment noise-induced polarization: the main challenge in macrophages’ immunotherapy for cancer

  2024cites this paper
• Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma

  2024cites this paper
• Cellular senescence in reproduction: a two-edged sword

  2024cites this paper
• Understanding the complexity of p53 in a new era of tumor suppression.

  2024cites this paper
• Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer.

  2024cites this paper
• Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression

  2024cites this paper
• The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis

  2024cites this paper
• Complex p53 dynamics regulated by miR-125b in cellular responses to reactive oxidative stress and DNA damage

  2024cites this paper
• The cell cycle inhibitor p21CIP1 is essential for irinotecan-induced senescence and plays a decisive role in re-sensitization of temozolomide-resistant glioblastoma cells to irinotecan.

  2024cites this paper
• Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks.

  2024cites this paper
• Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications

  2024cites this paper
• Low-Level MDM2 Amplification by FISH: An Institutional Experience With a Diagnostic Dilemma

  2024cites this paper
• Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.

  2024cites this paper
• The Long Non-Coding RNA ANRIL in Cancers

  2023cites this paper
• Cellular carcinogenesis in preleukemic conditions: drivers and defenses

  2023cites this paper
• Stress-induced senescence in mesenchymal stem cells: Triggers, hallmarks, and current rejuvenation approaches.

  2023cites this paper
• Targeting Biomolecular Condensation and Protein Aggregation against Cancer.

  2023cites this paper
• Spontaneous p53 activation in middle-aged C57BL/6 mice mitigates the lifespan-extending adaptive response induced by low-dose ionizing radiation

  2023cites this paper
• rs77283072 influences breast cancer susceptibility by regulating CDKN2A expression.

  2023cites this paper
• Homozygous DBF4 mutation as a cause for severe congenital neutropenia.

  2023cites this paper
• hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex

  2023cites this paper
• Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types

  2023cites this paper
• Pathogenesis and therapeutic implications of EBV-associated epithelial cancers

  2023cites this paper
• Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis and Treatment.

  2023cites this paper
• Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis

  2023cites this paper
• The matrix microenvironment influences but does not dominate tissue-specific stem cell lineage differentiation

  2023cites this paper
• Bmi-1: A master regulator of head and neck cancer stemness

  2023cites this paper
• A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle

  2023cites this paper
• The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer

  2023cites this paper
• The Role of p53 in HIV Infection

  2023cites this paper
• Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer

  2023cites this paper
• The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN

  2023cites this paper
• Review: MDMX plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies.

  2023cites this paper
• Plant hormone-mediated stress regulation responses in fruit crops- a review

  2022cites this paper
• TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer

  2022cites this paper
• Screening of potential novel candidate genes in schwannomatosis patients

  2022cites this paper
• A common pathway to cancer: Oncogenic mutations abolish p53 oscillations.

  2022cites this paper
• Ribosomopathies and cancer: pharmacological implications

  2022cites this paper
• Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention

  2022cites this paper
• Nucleolar stress: From development to cancer.

  2022cites this paper
• Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function

  2022influential citation
• Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma

  2022cites this paper
• A BDNF-TrkB autocrine loop enhances senescent cell viability

  2022cites this paper
• P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors

  2022cites this paper
• The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review.

  2022cites this paper
• Biology of cartilage tumor family

  2022cites this paper
• Metastatic Meningioma of the Neck: A Case Report and Systematic Review

  2022cites this paper
• Induction of Immune-Stimulating Factors and Oncolysis Upon p14ARF Gene Transfer in Melanoma Cell Lines

  2022influential citation
• Gundelia tournefortii inhibits hepatocellular carcinoma progression by lowering gene expression of the cell cycle and hepatocyte proliferation in immunodeficient mice.

  2022cites this paper
• Phospho-SIM and exon8b of PML protein regulate formation of doxorubicin-induced rDNA-PML compartment.

  2022cites this paper
• Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response

  2022cites this paper
• An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer

  2022cites this paper
• The management of hereditary melanoma, FAMMM syndrome and germline CDKN2A mutations: a narrative review

  2022cites this paper
• Genetic and biological hallmarks of colorectal cancer

  2021cites this paper
• Early growth response 2 (EGR2) is a novel regulator of the senescence programme

  2021cites this paper
• The redox-senescence axis and its therapeutic targeting

  2021cites this paper
• Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

  2021cites this paper
• Impaired Differentiation of Chronic Obstructive Pulmonary Disease Bronchial Epithelial Cells Grown on Bronchial Scaffolds

  2021cites this paper
• Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation

  2021cites this paper
• Overexpressed tumor protein p53 and the impaired function in aggressively growing calcifying odontogenic cyst: a case report

  2021cites this paper
• An interdependent network of functional enhancers regulates transcription and EZH2 loading at the INK4a/ARF locus

  2021cites this paper
• Molecular landscape of Hereditary Melanoma.

  2021cites this paper
• G protein Coupled Receptor Kinase 5 Modifies the Nucleolar Stress Response Activated by Actinomycin D.

  2021cites this paper
• Oncogenic alterations in the p53 pathway abolish oscillatory competence

  2021cites this paper
• Regulation of p53 by E3s

  2021cites this paper
• Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

  2021cites this paper
• Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!

  2021cites this paper
• Regulation of p53 stability as a therapeutic strategy for cancer.

  2021cites this paper
• Damsel in distress calling on her knights: Illuminating the pioneering role of E3 ubiquitin ligases in guarding the genome integrity.

  2021cites this paper
• CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma

  2021cites this paper
• Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

  2021cites this paper
• The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia

  2021cites this paper
• Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy

  2021cites this paper
• MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1.

  2021cites this paper
• Stem cells immortalized by hTERT perform differently from those immortalized by SV40LT in proliferation, differentiation, and reconstruction of matrix microenvironment.

  2021cites this paper
• Skin Cancer: Molecular Biomarker for Diagnosis, Prognosis, Prevention, and Targeted Therapy

  2021cites this paper
• The ion channel TRPM7 regulates zinc-depletion-induced MDMX degradation

  2021cites this paper
• Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis

  2021cites this paper
• Cellular senescence or stemness: hypoxia flips the coin

  2021cites this paper
• Basic Research

  2021cites this paper
• The Paradoxical Role of Cellular Senescence in Cancer

  2021cites this paper
• CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation

  2021cites this paper
• Exploring the Molecular Landscape of Cutaneous Melanoma

  2020cites this paper
• Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer

  2020cites this paper
• Mitochondrial cytochrome c liberates the nucleophosmin-sequestered ARF tumor suppressor in the nucleolus

  2020influential citation
• The Genomic Landscape of Meningiomas

  2020cites this paper
• Current Molecular Markers of Melanoma and Treatment Targets

  2020cites this paper
• Tailored treatment in mantle cell lymphoma

  2020cites this paper